Association of Injection Practices and Overdose With Drug Use Typologies: A Latent Class Analysis Among People Who Inject Drugs in Baltimore, 2017

Overview

Journal AIDS Educ Prev

Specialties Infectious Diseases
Medical Education

Date 2019 Jul 31

PMID 31361518

Citations 10

Authors

Rachel E Gicquelais

Becky L Genberg

Jacquie Astemborski

David D Celentano

Gregory D Kirk

Shruti H Mehta

Affiliations

Soon will be listed here.

Abstract

Increasing overdose mortality and new HIV outbreaks in the U.S. highlight the need to identify risk behavior profiles among people who inject drugs (PWID). We characterized latent classes of drug use among a community-based sample of 671 PWID in Baltimore during 2017 and evaluated associations of these classes with sharing syringes, obtaining syringes from pharmacies or syringe services programs (SSPs), and nonfatal overdose in the past 6 months. We identified three classes of current drug use: infrequent use (76% of participants), prescription drug use (12%), and heroin and/or cocaine injection (12%). PWID in the heroin and/or cocaine injection and prescription drug use classes had higher odds of both overdose and sharing syringes (relative to infrequent use). PWID in the prescription drug use class were 64% less likely to obtain syringes through SSPs/pharmacies relative to heroin and/or cocaine injection. Harm reduction programs need to engage people who obtain prescription drugs illicitly.

Citing Articles

Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis.

Grantz K, Cepeda J, Astemborski J, Kirk G, Thomas D, Mehta S J Viral Hepat. 2024; 32(4):e13999.

PMID: 39234877 PMC: 11880348. DOI: 10.1111/jvh.13999.

Longitudinal patterns of use of stimulants and opioids in the AIDS linked to the IntraVenous experience cohort, 2005-2019.

Rudolph J, Cepeda J, Astemborski J, Kirk G, Mehta S, German D Int J Drug Policy. 2024; 126:104364.

PMID: 38408416 PMC: 11056308. DOI: 10.1016/j.drugpo.2024.104364.

Screening Incarcerated Women for Opioid Use Disorder.

Staton M, Tillson M, Levi M, Webster M, Oser C, Leukefeld C J Drug Issues. 2023; 54(1):57-73.

PMID: 38046434 PMC: 10688603. DOI: 10.1177/00220426231151595.

Differential risks of syringe service program participants in Central Ohio: a latent class analysis.

Moon K, Bryant I, Trinh A, Hasenstab K, Carter B, Barclay R Harm Reduct J. 2023; 20(1):97.

PMID: 37507721 PMC: 10386257. DOI: 10.1186/s12954-023-00824-8.

A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development.

Glick J, Zhang L, Rosen J, Yaroshevich K, Atiba B, Pelaez D JMIR Form Res. 2023; 7:e42418.

PMID: 37052977 PMC: 10141312. DOI: 10.2196/42418.

References

. HIV surveillance--United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011; 60(21):689-93. View

Song J, Safaeian M, Strathdee S, Vlahov D, Celentano D . The prevalence of homelessness among injection drug users with and without HIV infection. J Urban Health. 2001; 77(4):678-87. PMC: 3456762. DOI: 10.1007/BF02344031. View

Latkin C, Vlahov D . Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users. Addiction. 1998; 93(8):1191-7. DOI: 10.1046/j.1360-0443.1998.93811917.x. View

Puzhko S, Roy E, Jutras-Aswad D, Artenie A, Fortier E, Zang G . High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention. Int J Drug Policy. 2017; 47:61-68. DOI: 10.1016/j.drugpo.2017.05.027. View

Park J, Weir B, Allen S, Chaulk P, Sherman S . Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduct J. 2018; 15(1):34. PMC: 6034235. DOI: 10.1186/s12954-018-0240-z. View

Hunter K, Park J, Allen S, Chaulk P, Frost T, Weir B . Safe and unsafe spaces: Non-fatal overdose, arrest, and receptive syringe sharing among people who inject drugs in public and semi-public spaces in Baltimore City. Int J Drug Policy. 2018; 57:25-31. PMC: 6499603. DOI: 10.1016/j.drugpo.2018.03.026. View

Morris M, Evans J, Montgomery M, Yu M, Briceno A, Page K . Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA. PLoS One. 2014; 9(10):e109282. PMC: 4186818. DOI: 10.1371/journal.pone.0109282. View

Khosla N, Juon H, Kirk G, Astemborski J, Mehta S . Correlates of non-medical prescription drug use among a cohort of injection drug users in Baltimore City. Addict Behav. 2011; 36(12):1282-7. PMC: 3179799. DOI: 10.1016/j.addbeh.2011.07.046. View

Lanza S, Collins L, Lemmon D, Schafer J . PROC LCA: A SAS Procedure for Latent Class Analysis. Struct Equ Modeling. 2011; 14(4):671-694. PMC: 2785099. DOI: 10.1080/10705510701575602. View

10.

Munoz F, Burgos J, Cuevas-Mota J, Teshale E, Garfein R . Individual and socio-environmental factors associated with unsafe injection practices among young adult injection drug users in San Diego. AIDS Behav. 2014; 19(1):199-210. PMC: 4265001. DOI: 10.1007/s10461-014-0815-y. View

11.

Mackesy-Amiti M, Donenberg G, Ouellet L . Psychiatric correlates of injection risk behavior among young people who inject drugs. Psychol Addict Behav. 2014; 28(4):1089-95. PMC: 4274210. DOI: 10.1037/a0036390. View

12.

Marshall B, Green T, Yedinak J, Hadland S . Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities. Int J Drug Policy. 2016; 31:25-31. PMC: 4975034. DOI: 10.1016/j.drugpo.2016.01.022. View

13.

Zibbell J, Hart-Malloy R, Barry J, Fan L, Flanigan C . Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics. Am J Public Health. 2014; 104(11):2226-32. PMC: 4202941. DOI: 10.2105/AJPH.2014.302142. View

14.

Macalino G, Celentano D, Latkin C, Strathdee S, Vlahov D . Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002; 14(5):367-78. DOI: 10.1521/aeap.14.6.367.24075. View

15.

Bruneau J, Roy E, Arruda N, Zang G, Jutras-Aswad D . The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. Addiction. 2012; 107(7):1318-27. DOI: 10.1111/j.1360-0443.2012.03803.x. View

16.

Anagnostopoulos A, Abraham A, Genberg B, Kirk G, Mehta S . Prescription drug use and misuse in a cohort of people who inject drugs (PWID) in Baltimore. Addict Behav. 2018; 81:39-45. PMC: 5845821. DOI: 10.1016/j.addbeh.2018.01.024. View

17.

Zlotorzynska M, Weidle P, Paz-Bailey G, Broz D . Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities. Int J Drug Policy. 2018; 62:51-58. PMC: 11375483. DOI: 10.1016/j.drugpo.2018.08.019. View

18.

Kuramoto S, Bohnert A, Latkin C . Understanding subtypes of inner-city drug users with a latent class approach. Drug Alcohol Depend. 2011; 118(2-3):237-43. PMC: 3153580. DOI: 10.1016/j.drugalcdep.2011.03.030. View

19.

Martins S, Sampson L, Cerda M, Galea S . Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature. Am J Public Health. 2015; 105(11):2373. PMC: 4605171. DOI: 10.2105/AJPH.2015.302843a. View

20.

Genberg B, Gillespie M, Schuster C, Johanson C, Astemborski J, Kirk G . Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland. Addict Behav. 2013; 38(12):2868-73. PMC: 3805723. DOI: 10.1016/j.addbeh.2013.08.008. View